INNOVATE Corp. · NYSE:VATE
INNOVATE — Q3 2026 Earnings Presentation
17 slides from INNOVATE's earnings presentation, Nov 12, 2026
Slide 1: Q3 2026 Earnings Release Supplement
INNOVATE Corp. 2026 INNOVATE Corp. Q3 2026 Earnings Release Supplement November 12, 2026
Slide 2: Safe Harbor Disclaimers: Forward-Looking Statements
INNOVATE Corp. 2026 Safe Harbor Disclaimers 2 Cautionary Statement Regarding Forward-Looking Statements Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This presentation contains, and certain oral statements made by our representatives from time to time may contain,
Slide 3: Safe Harbor Disclaimers: Non-GAAP Financial Measures
INNOVATE Corp. 2026 Safe Harbor Disclaimers 3 Non-GAAP Financial Measures In this earnings release supplement, INNOVATE refers to certain financial measures that are not presented in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”), including Total Adjusted EBITDA (excludi
Slide 4: Third Quarter Highlights
INNOVATE Corp. 2026 ■ DBM Global Inc. ("DBMG") delivered exceptional results in its final quarter under INNOVATE ownership with year- over-year revenue growth of ~45%. ■ As previously announced, on October 5, 2026, INNOVATE completed the sale of DBM Global, Inc. ("DBMG") to IES Holdings, Inc. ("IES"
Slide 5: Segment Highlights
INNOVATE Corp. 2026 ■ MediBeacon expanded engagement to over 120 healthcare institutions as commercialization of the TGFR System advances. ■ Advanced key reimbursement initiatives, including engagement with CMS and payors. ■ Secured orders for 600 TGFR Monitors in China, with shipments planned throu
Slide 6: Consolidated Q3 Results
INNOVATE Corp. 2026 Consolidated Q3 Results ■ Revenue increased $148.4M or 42.8% driven primarily by our Infrastructure segment, which was partially offset by decreases at our Spectrum and Life Sciences segments. The increase at our Infrastructure segment was primarily driven by the timing and size
Slide 7: Segment Highlights - Infrastructure
INNOVATE Corp. 2026 ■ 45.0% revenue increase primarily driven by the timing and size of projects at DBMG's commercial structural steel fabrication and erection business, which had increased activity subsequent to the comparable period on certain large construction projects, combined with changes in
Slide 8: Segment Highlights - Life Sciences
INNOVATE Corp. 2026 ■ MediBeacon continued to advance commercialization of the TGFR System, with engagement expanding to more than 120 U.S. medical institutions and customer shipments, research and utilization underway at leading medical centers. ■ MediBeacon continued to advance reimbursement initi
Slide 9: Segment Highlights - Spectrum
INNOVATE Corp. 2026 Financials ($ millions) 3Q26 3Q25 Revenue $ 3.7 $ 5.6 Net Income (Loss)(1) $ 25.9 $ (5.9) Adjusted EBITDA (2) $ 0.3 $ 1.0 9 Segment Highlights - Spectrum HC2 Broadcasting ("Broadcasting") Overview (1) Net Income (Loss) attributable to INNOVATE Corp. (2) See Appendix for reconcili
Slide 10: Debt Summary and Maturity Profile
INNOVATE Corp. 2026 (1) Debt Maturity Profile excludes held for sale liabilities, Preferred Stock and operating leases. (2) Debt Amortization and Maturity Profile chart presents debt annual amortization and maturity payments, excluding exit fees and interest payments. (3) 2026 debt amortization incl
Slide 11: Appendix: Select GAAP Financials & Non-GAAP Reconciliations
INNOVATE Corp. 2026 Appendix Select GAAP Financials & Non-GAAP Reconciliations
Slide 12: Selected GAAP Financials: Income Statement
INNOVATE Corp. 2026 INNOVATE Selected GAAP Financials Income Statement - Unaudited (in millions) Three Months Ended September 30, Nine Months Ended September 30, 2026 2025 2026 2025 Revenue $ 495.5 $ 347.1 $ 1,281.9 $ 863.3 Cost of revenue 418.6 297.4 1,072.0 722.5 Gross profit 76.9 49.7 209.9 140.8
Slide 13: Reconciliation of GAAP Income to Adjusted EBITDA: Three Months 2026
INNOVATE Corp. 2026 Reconciliation of U.S. GAAP Income (Loss) to Adjusted EBITDA 13 (in millions) Three Months Ended September 30, 2026 Infrastructure Life Sciences Spectrum Non-Operating Corporate Other and Eliminations INNOVATE Net income (loss) attributable to INNOVATE Corp. $ 25.2 $ (3.0) $ 25.9
Slide 14: Reconciliation of GAAP Income to Adjusted EBITDA: Nine Months 2026
INNOVATE Corp. 2026 Reconciliation of U.S. GAAP Income (Loss) to Adjusted EBITDA 14 (in millions) Nine Months Ended September 30, 2026 Infrastructure Life Sciences Spectrum Non-Operating Corporate Other and Eliminations INNOVATE Net income (loss) attributable to INNOVATE Corp. $ 60.9 $ (8.6) $ 27.8
Slide 15: Reconciliation of GAAP Income to Adjusted EBITDA: Three Months 2025
INNOVATE Corp. 2026 Reconciliation of U.S. GAAP Income (Loss) to Adjusted EBITDA 15 (in millions) Three Months Ended September 30, 2025 Infrastructure Life Sciences Spectrum Non-Operating Corporate Other and Eliminations INNOVATE Net income (loss) attributable to INNOVATE Corp. $ 8.8 $ (4.6) $ (5.9)
Slide 16: Reconciliation of GAAP Income to Adjusted EBITDA: Nine Months 2025
INNOVATE Corp. 2026 Reconciliation of U.S. GAAP Income (Loss) to Adjusted EBITDA 16 (in millions) Nine Months Ended September 30, 2025 Infrastructure Life Sciences Spectrum Non-Operating Corporate Other and Eliminations INNOVATE Net income (loss) attributable to INNOVATE Corp. $ 18.9 $ (18.7) $ (17.
Slide 17: Reconciliation of GAAP Income to Adjusted EBITDA: Infrastructure LTM
INNOVATE Corp. 2026 Reconciliation of U.S. GAAP Income (Loss) to Adjusted EBITDA 17 (in millions) Infrastructure Three Months Ended December 31, 2025 Nine Months Ended September 30, 2026 LTM September 30, 2026 Net income attributable to INNOVATE Corp. $ 10.6 $ 60.9 $ 71.5 Adjustments to reconcile ne